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SHORT REPORTS
Increase in Extracellular Hydration  
Status After Initiating Peritoneal  
Dialysis Electively
Renal replacement therapy is designed to treat uremic symp-
toms and correct hypervolemia. We hypothesized that starting 
peritoneal dialysis (PD) should reduce overhydration, and we 
measured body composition and hydration status using bio-
impedance in PD patients prior to training and then at the 
first assessment of peritoneal membrane function. We studied 
100 consecutive patients with a planned start to PD, without 
peritoneal infections or mechanical catheter problems, mean 
age 54.7 ± 17.1 years, 57% male and 25% diabetic. Extracellular 
water (ECW) overhydration increased from -0.06 (-1.21 to 0.97) L 
to 0.96 (0.50 to 3.01) L, p < 0.001. Fat mass increased from 
22.7 ± 11.1 to 23.7 ± 11.3 kg, p = 0.007). The change in ECW/
total body water (TBW) was associated with age (β 0.065, p < 
0.001), increasing comorbidity (β 1.107, p = 0.005), faster 
peritoneal protein transport (β 1.84, p < 0.04), and negatively 
with serum albumin (β -0.208, p < 0.001), and residual renal 
function (β -0.725, p = 0.026). Patients who had an increase 
in ECW/TBW had higher C-reactive protein (CRP) both before 
starting (16.8 ± 24.1 vs 7.7 ± 18.9 mg/L), and when established 
on PD (15.0 ± 31.8 vs 4.6 ± 5.1 mg/L), p < 0.05. Rather than 
a reduction in ECW hydration status, overhydration increased 
after starting PD. This was greater for older more comorbid 
patients and those with an inflammatory milieu and lower 
residual renal function. These factors should be considered 
when deciding upon initial PD prescriptions to limit ECW over-
hydration before information on peritoneal membrane function 
becomes available.
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Peritoneal dialysis (PD) is designed to correct overhydra-tion by removing excess fluid by ultrafiltration. Exposure 
to peritoneal dialysates potentially increases peritoneal capil-
lary surface area, so clinical guidelines recommend delaying 
assessments of peritoneal membrane function for at least 
6 weeks after starting PD, to allow for adaptation within the 
peritoneal cavity (1). We wished to determine whether initia-
tion of PD improves hydration status.
STUDY DESIGN AND METHODS
We prospectively studied 100 consecutive patients attend-
ing for their first assessment of peritoneal membrane function, 
6 – 8 weeks after training, and compared paired bioimpedance 
assessments. All patients started PD electively, none as an 
emergency, or urgent start, and no patient had suffered perito-
nitis or mechanical problems with their catheter. Ninety-eight 
patients used lactate- and glucose-containing dialysates, and 
2 used neutral pH dialysates due to infusion pain. Icodextrin 
7.5% was used as the day dwell for all patients using automated 
PD (APD) with a day dwell and as a night-time dwell for those 
treated by continuous ambulatory PD (CAPD) (Baxter Health-
care, Deerfield, Illinois, USA).
Serum biochemistry samples were analyzed using standard 
methods and 4-hour peritoneal equilibration tests (PET) used 
2 liters of 2.27% dialysate. Peritoneal dialysis adequacy was 
calculated from 24-hour spent dialysate samples, and residual 
renal function (RRF) from 24-hour urine collections. Normal-
ized protein nitrogen appearance rate (nPNA) was estimated 
from 24-hour urinary and peritoneal urea losses. Patient 
comorbidity used Stoke-Davies grading. 
Multi-frequency bio-impedance analysis (MFBIA) used a 
standardized protocol (InBody 720 Body Composition Analysis, 
Biospace, Seoul, South Korea) (2). Volume status was deter-
mined by the ratio between extracellular and total body water 
(ECW/TBW ratio) (3), and by calculating ECW overhydration (4). 
This audit fully complied with UK NHS clinical audit guide-
lines. Statistical analysis was by standard methods using 
GraphPad (GraphPad version 6.0, San Diego, CA, USA) and 
SPSS (SPSS version 22.0, Chicago, IL, USA), and statistical 
significance was taken at p < 0.05. 
RESULTS
The mean patient age was 54.7 ± 17.1 years, 57% male, and 
25% diabetic. 
Extracellular water overhydration increased from a median 
of -0.06 L (-1.21 to 0.97) to 0.96 L (0.50 to 3.01), p < 0.001. 
Although there was no significant change in body weight, 
(75.5 ± 18.5 vs 75.2 ± 18.4 kg), there were falls in body cell 
mass (BCM) (33.5 ± 8.7 vs 32.7 ± 8.4 kg, p = 0.031) and ICW 
(23.64 ± 6.02 vs 23.21 ± 5.97 L, p = 0.033), but neither the fall 
in ECW (15.31 ± 3.96 vs 15.08 ± 3.78 L), nor skeletal muscle 
mass (28.5 ± 7.9 vs 28.0 ± 7.9 kg) were significant. There was a 
gain in fat mass (from 22.7 ± 11.1 to 23.7 ± 11.3, p = 0.007 kg), 
and percentage body fat (from 29.8 ± 10.9 to 30.9 ± 10.9%, 
p = 0.013). Serum albumin fell (39.0 ± 5.6 vs 37.5 ± 5.0 g/L, 
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p < 0.001), but there was no significant change in C-reactive 
protein (CRP); 12.8 ± 22 vs 10.3 ± 24 mg/L.
Patients were divided into those who had an increase in ECW/
TBW and those who had either no change or a decrease in ECW/
TBW (Table 1). Body composition was not different. Those with 
increased ECW/TBW had higher CRP. There were no differences in 
RRF, 24-hour ultrafiltration, serum albumin, comorbidity grades, 
diabetes, age, or sex, but there was a difference in ethnicity. 
On univariate analysis, ECW/TBW was associated with age, 
comorbidity, serum CRP, PET creatinine transporter, serum 
creatinine, and negatively with serum albumin (Figure 1), 
nPNA, PET ultrafiltration volume, and RRF (Supplementary 
Table). On multivariable analysis the change in ECW/TBW was 
independently associated with age (β 0.065, p < 0.001), 
increasing comorbidity (β 1.107, p = 0.005), faster peritoneal 
protein transport (β 1.84, p < 0.04), and negatively with serum 
TABLE 1 








Age, years 55±18 55±16 >0.05
Male sex 66.7% 45.7% 0.056
Diabetes mellitus 31.5% 17.4% 0.105
Caucasian 53.7% 30.4%
Afro-Caribbean 24.1% 21.7%
South Asian 14.8% 43.5% 0.035
Comorbidityb grade 0 40.7% 45.7%
Comorbidity grade 1 42.6% 50%
Comorbidity grade 2 16.7% 4.3% 0.32
Weight, kg pre-PD 74.7±17.0 76.7±20.5 >0.05
Weight, kg at PET 75.3±16.6 75.6±20.9 >0.05
ICW, liters pre-PD 23.59±5.97 23.25±6.26 >0.05
ICW, liters at PET 23.18±5.56 23.04±6.62 >0.05
ECW, liters pre-PD 15.10±3.90 15.14±4.15 >0.05
ECW, liters at PET 15.27±3.66 14.73±4.03 >0.05
TBW, liters pre-PD 38.70±9.77 38.40±10.33 >0.05
TBW, liters at PET 38.44±9.15 37.77±10.59 >0.05
Skeletal muscle mass pre-PD, kg 29.04±8.19 28.3±7.42 >0.05
Skeletal muscle mass at PET, kg 28.50±7.38 28.05±8.04 >0.05
Fat mass pre-PD, kg 22.27±11.48 23.83±10.92 >0.05
Fat mass at PET, kg 23.37±10.74 24.25±12.03 >0.05
Serum albumin, g/L pre-PD 39±6 39±5 >0.05
Serum albumin, g/L at PET 37±5 38±4 >0.05
CRP, mg/L pre-PD 16.78±24.10 7.67±18.9 <0.05
CRP, mg/L at PET 15.02±31.81 4.57±5.11 <0.05
Urine volume, mL/day 1399±907 1392±927 >0.05
RRF, mL/min/1.73 m2 6.9 (3.2–9.9) 5.9 (3.2–9.3) >0.05
Liters creatinine cleared/wk/1.73 m2 70±49 82±70 >0.05
4-hour D/P creatinine 0.75±0.13 0.70±0.15 >0.05
4-hour D/P protein 0.11±0.07 0.12±0.19 >0.05
PET ultrafiltration volume, mL 300 (100–500) 200 (100–300) <0.05
24-hour peritoneal ultrafiltration, mL 400 (82–794) 353 (78–739) >0.05
APD dry day 16.7% 26.1% >0.05
CAPD 24.1% 13.0% >0.05
APD wet day 59.3% 60.9% 0.27
Frusemide dose pre-PD, mg/day 80 (0-80) 80 (0-80) >0.05
Frusemide dose at PET, mg/day 250 (250–250) 250 (250–250) >0.05
ECW = extracellular water; TBW = total body water; ICW = intracellular water; PD = peritoneal dialysis; PET = peritoneal equilibration test; CRP = 
C-reactive protein; RRF = residual renal function (combined urinary urea and creatinine clearance); APD = automated PD (over-night cycler); 
CAPD = continuous ambulatory PD; D/P = dialysate/plasma; SD = standard deviation; IQR = interquartile range.
a  Comparison of patients with increase in ECW/TBW at the time of first peritoneal transport assessment compared with ECW/TBW prior to PD 
training compared with patients with stable or falling ECW/TBW. 
b Stoke-Davies comorbidity grade. 
Data expressed as mean±SD, median (IQR) or percentage.
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albumin (β -0.208, p < 0.001), and RRF (β -0.725, p = 0.026) 
(Supplementary Table).
DISCUSSION
Dialysis is initiated to treat uremic symptoms and correct 
hypervolemia. One would expect that establishing patients on 
PD would result in an improvement in hydration and nutritional 
status. However, we found that patients electively starting PD, 
with no mechanical complications or peritoneal infections, had 
a relative increase in ECW hydration. This was associated with a 
fall in serum albumin, which could represent dilution due to ECW 
expansion (5), and an increase in fat mass potentially second-
ary to peritoneal glucose absorption. We divided patients into 
those with increased ECW/TBW or stable/fall in ECW/TBW (3), 
and those with increased ECW/TBW had higher serum CRP, and 
greater fall in albumin. Inflammation may increase extravas-
cular albumin transfer and ECW expansion (6) and loss of BCM. 
The ECW/TBW ratio was positively associated with age, 
serum CRP, faster peritoneal creatinine transport and comor-
bidity, and negatively with nPNA, serum albumin, and RRF. As 
such, an increased ECW/TBW ratio could be associated with 
both systemic and local peritoneal inflammation. Inflam-
mation can increase large pore transport, and we observed 
a stepwise increase in ECW/TBW as 4-hour dialysate/plasma 
(D/P) protein increased. Residual renal function was negatively 
associated with ECW/TBW (7). However, ECW expansion does 
not necessarily correlate with plasma volume expansion, as 
this excess fluid is not readily accessible (8,9). 
Our observational study can only report associations and 
not causality. Limitations to our study include no baseline 
assessment of RRF, however as these were stable patients 
starting PD it is unlikely that there would have been major 
changes in RRF in such a short time. Our study population 
predominantly used APD, and the shorter dwell time can lead 
to differences in water compared with sodium clearances with 
glucose dialysates. However, most APD patients also had a 
daytime icodextrin exchange.
Our study demonstrates that initiating PD is associated 
with a relative increase in ECW hydration. The change in ECW/
TBW was greater in those patients who were older and more 
comorbid and had lower serum albumin, higher CRP, and faster 
peritoneal protein transport, suggesting that this is driven by 
an inflammatory phenotype, and greater for those with less 
RRF. These findings should be considered when first prescribing 
PD regimens for patients initiating PD.
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Retroperitoneal Laparoscopic Radical 
Nephrectomy Allows Continuation of 
Peritoneal Dialysis in Patients with  
End-Stage Renal Disease
Patient outcomes for retroperitoneal laparoscopic radical nephrec-
tomy (RLRN) in adults on peritoneal dialysis (PD) have not been 
Figure 1 — Serum albumin and extracellular water (ECW)/total body 
water (TBW) ratio at time of first peritoneal membrane assessment. 
Pearson correlation r=-0.54, p<0.001.
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